Back to Search
Start Over
Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway.
- Source :
-
Journal of neuroscience research [J Neurosci Res] 2016 Jan; Vol. 94 (1), pp. 50-61. Date of Electronic Publication: 2015 Oct 01. - Publication Year :
- 2016
-
Abstract
- The midbrain ventrolateral periaqueductal gray (VL-PAG) is a key component that mediates pain modulation. Although spinal cord glial cells appear to play an important role in chronic pain development, the precise mechanisms involving descending facilitation pathways from the PAG following nerve injury are poorly understood. This study shows that cellular events that occur during glial activation in the VL-PAG may promote descending facilitation from the PAG during neuropathic pain. Chronic constriction nerve injury (CCI) was induced by ligature construction of the sciatic nerve in male Sprague-Dawley rats. Behavioral responses to noxious mechanical (paw withdrawal threshold; PWT) and thermal (paw withdrawal latency; PWL) stimuli were evaluated. After CCI, immunohistochemical and Western blot analysis of microglia and astrocytes in the VL-PAG showed morphological and quantitative changes indicative of activation in microglia and astrocytes. Intra-VL-PAG injection of microglial or astrocytic inhibitors attenuated PWT and PWL at days 7 and 14, respectively, following CCI. We also evaluated the effects of intra-VL-PAG administration of the phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) inhibitor SB 203580 at day 7 after CCI. This treatment abolished microglial activation and produced a significant time-dependent attenuation of PWT and PWL. Western blot analysis showed localized expression of p-p38 in the VL-PAG after CCI. P-p38 was expressed in labeled microglia of the VL-PAG but was not present in astrocytes and neurons on day 7 after CCI. These results demonstrate that CCI-induced neuropathic pain is associated with glial activation in the VL-PAG, which likely participates in descending pain facilitation through the p38 MAPK signaling pathway.<br /> (© 2015 Wiley Periodicals, Inc.)
- Subjects :
- Animals
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Calcium-Binding Proteins metabolism
Disease Models, Animal
Glial Fibrillary Acidic Protein metabolism
Hyperalgesia drug therapy
Hyperalgesia physiopathology
Imidazoles therapeutic use
Male
Microfilament Proteins metabolism
Pain Measurement
Pain Threshold drug effects
Phosphopyruvate Hydratase metabolism
Pyridines therapeutic use
Rats
Rats, Sprague-Dawley
Sciatica drug therapy
Signal Transduction drug effects
Time Factors
Neuroglia pathology
Periaqueductal Gray pathology
Sciatica pathology
Sciatica physiopathology
Signal Transduction physiology
p38 Mitogen-Activated Protein Kinases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1097-4547
- Volume :
- 94
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of neuroscience research
- Publication Type :
- Academic Journal
- Accession number :
- 26423029
- Full Text :
- https://doi.org/10.1002/jnr.23672